Balance test results. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Mechanism analysis results. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Endogenous test results. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Heterogeneity analysis results. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Robustness test results. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Baseline results of the impact of RLM on HWSW. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

The influencing factors of RLM. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Variable definitions and basic statistics. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Average and marginal effects of RLM on HWSW. by Yi Yu (28902)

“…Specifically, with every 1% increase in RLM, the likelihood of rural residents’ HWSW will decrease by 3.5%. …”

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer deaths by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Hospitalizations for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized hospitalization rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Mortality for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Joinpoint regression trends in age-standardized hospitalization and mortality rates of HPV-associated cancers in Mexico (2011-2019). by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized mortality rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer hospitalizations by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

A Comparison of Pediatric Prehospital Opioid Encounters and Social Vulnerability by Stephen Sandelich (19991783)

Subjects:

Age distribution and median age at hospitalization and death by HPV-associated cancer type and sex, Mexico, 2011–2019. by Juan Carlos Orengo (21546581)

Subjects:

Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma <i>In Vivo</i> by Mingyue Li (1582399)

“…The probe exhibits a consistent decrease in fluorescence intensity with an increase in solvent polarity, demonstrating excellent photostability and biocompatibility. …”